Cargando…

A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus

Type 2 diabetes (T2DM) is a chronic metabolic disorder. Impaired insulin secretion, enhanced hepatic glucose production, and suppressed peripheral glucose use are the main defects responsible for developing the disease. Besides, the pathophysiology of T2DM also includes enhanced glucagon secretion,...

Descripción completa

Detalles Bibliográficos
Autor principal:	Belete, Tafere Mulaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959499/ https://www.ncbi.nlm.nih.gov/pubmed/32021494 http://dx.doi.org/10.2147/JEP.S226113

Ejemplares similares

Recent Progress in the Development of New Antimalarial Drugs with Novel Targets
por: Belete, Tafere Mulaw
Publicado: (2020)

Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets
por: Belete, Tafere Mulaw
Publicado: (2023)

Recent Updates on the Development of Deuterium-Containing Drugs for the Treatment of Cancer
por: Belete, Tafere Mulaw
Publicado: (2022)

Recent Progress in the Development of Novel Mycobacterium Cell Wall Inhibitor to Combat Drug-Resistant Tuberculosis
por: Belete, Tafere Mulaw
Publicado: (2022)

A review on Promising vaccine development progress for COVID-19 disease
por: Belete, Tafere Mulaw
Publicado: (2020)

A review on Promising vaccine development progress for COVID-19 disease
por: Belete, Tafere Mulaw
Publicado: (2020)

The Current Status of Gene Therapy for the Treatment of Cancer
por: Belete, Tafere Mulaw
Publicado: (2021)

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
por: Mulaw Belete, Tafere
Publicado: (2020)

Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
por: Belete, Tafere Mulaw
Publicado: (2021)

Evaluation of Wound Healing and Anti-Inflammatory Activities of 80% Methanol Crude Extract and Solvent Fractions of Trichilia dregeana Sond (Meliaceae) Leaves in Mice
por: Shewaye, Daniel Gizachew, et al.
Publicado: (2023)

Patient satisfaction with antiretroviral therapy service provided by pharmacists in Dembia district health institutions, Northwest Ethiopia
por: Belete, Tafere Mulaw, et al.
Publicado: (2023)

Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
por: Yun, Soo Jin, et al.
Publicado: (2022)

Antidiarrheal Effect of 80% Methanol Extract and Fractions of Clerodendrum myricoides (Hochst.) Vatke (Lamiaceae) Leaf in Swiss Albino Mice
por: Desta, Getaye Tessema, et al.
Publicado: (2021)

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
por: Ortiz-Martínez, Margarita, et al.
Publicado: (2022)

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2010)

The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages
por: Yu, Yun, et al.
Publicado: (2020)

Prescription pattern and associated factors among pregnant women attending antenatal clinics in University of Gondar, North West Ethiopia
por: Belete, Tafere Mulaw, et al.
Publicado: (2022)

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients
por: Chaudhary, Prateek, et al.
Publicado: (2013)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere, Gebrehiwot Gebremedhin, et al.
Publicado: (2020)

A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Antidiarrheal Activity of Hydromethanolic Root Extract and Solvent Fractions of Clutia abyssinica Jaub. & Spach. (Euphorbiaceae) in Mice
por: Zayede, Dessie, et al.
Publicado: (2020)

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
por: Wondafrash, Dawit Zewdu, et al.
Publicado: (2020)

Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Literature-Based Discovery of Salivary Biomarkers for Type 2 Diabetes Mellitus
por: Srinivasan, Mythily, et al.
Publicado: (2015)

Recent advances in understanding/managing type 2 diabetes mellitus
por: Aschner, Pablo
Publicado: (2017)

Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Wang, Xuekun, et al.
Publicado: (2022)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Lee, Joonyub, et al.
Publicado: (2021)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Lee, Joonyub, et al.
Publicado: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: Donovan, Peter J, et al.
Publicado: (2010)

Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice
por: Shah, Najeeb, et al.
Publicado: (2021)

Long-Term Protective Effect of Lactation on the Development of Type 2 Diabetes in Women With Recent Gestational Diabetes Mellitus
por: Ziegler, Anette-G., et al.
Publicado: (2012)

Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus
por: Zang, Liqing, et al.
Publicado: (2017)

Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone
por: Shillington, Alicia C, et al.
Publicado: (2015)

Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Recent Advances in In-Vitro Assays for Type 2 Diabetes Mellitus: An Overview
por: Vhora, Nazmina, et al.
Publicado: (2021)

Assessment of Achievement of American Diabetes Association (ADA) Targets in Patients with Type 2 Diabetes Mellitus at a Tertiary Care Centre in Eastern Nepal
por: Baranwal, Jouslin K, et al.
Publicado: (2020)

Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus
por: García-Ulloa, Ana Cristina, et al.
Publicado: (2021)

Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
por: Yang, Jiayue, et al.
Publicado: (2021)

A novel method for causal structure discovery from EHR data and its application to type-2 diabetes mellitus
por: Shen, Xinpeng, et al.
Publicado: (2021)

Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
por: Bannister, Margaret, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nlvidhj92oteaq06pr5t7h2kfl